ACTB-1003
Catalog No. A14431
ACTB-1003是一种口服激酶抑制剂,靶向癌症突变(FGFR抑制),血管生成(抑制VEGFR2和Tie-2)并诱导凋亡(靶向PI3激酶下游的RSK和p70S6K。
Catalog Num | A14431 |
---|---|
M. Wt | 591.53 |
Formula | C27H26F5N7O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 939805-30-8 |
Synonyms | ACTB1003, ACTB 1003 |
SMILES | COCC1=C(N2C(=C1C3=CC(=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F)F)C(=NC=N2)N)CN5CCOCC5 |
ACTB-1003是一种口服激酶抑制剂,靶向癌症突变(FGFR抑制),血管生成(抑制VEGFR2和Tie-2)并诱导凋亡(靶向PI3激酶下游的RSK和p70S6K。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 16.91 mL | 84.53 mL | 169.05 mL |
0.5 mM | 3.38 mL | 16.91 mL | 33.81 mL |
1 mM | 1.69 mL | 8.45 mL | 16.91 mL |
5 mM | 0.34 mL | 1.69 mL | 3.38 mL |
*The above data is based on the productmolecular weight 591.53. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.